XIV Stock Recent News Daily Inverse VIX ST ETN Velocityshares

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Daily Inverse VIX ST ETN Velocityshares (XIV) 36.61 $XIV

Shares of XIV Up 12.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 07, 10:01AM CST
SmarTrend identified an Uptrend for VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) on October 21st, 2014 at $32.16. In approximately 2 weeks, VelocityShares Daily Inverse VIX ST ETN has returned 12.08% as of today's recent price of $36.04.
XIV: 36.61 (+0.54)

Look for Shares of VelocityShares Daily Inverse VIX ST ETN to Potentially Pullback after Yesterday's 1.24% Rise
Comtex SmarTrend(R) - Wed Nov 05, 3:59PM CST
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $34.56 to a high of $35.44. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $35.35 on volume of 11.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XIV: 36.61 (+0.54)

Watch for VelocityShares Daily Inverse VIX ST ETN to Potentially Pullback After Gaining 6.59% Yesterday
Comtex SmarTrend(R) - Tue Oct 28, 3:54PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $33.23 to a high of $35.01. Yesterday, the shares gained 6.6%, which took the trading range above the 3-day high of $32.95 on volume of 21.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XIV: 36.61 (+0.54)

VelocityShares Daily Inverse VIX ST ETN Down 18.6% Since SmarTrend Downtrend Call (XIV)
Comtex SmarTrend(R) - Tue Oct 21, 10:02AM CDT
SmarTrend identified a Downtrend for VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) on September 29th, 2014 at $38.96. In approximately 3 weeks, VelocityShares Daily Inverse VIX ST ETN has returned 18.63% as of today's recent price of $31.70.
XIV: 36.61 (+0.54)

Look for Shares of VelocityShares Daily Inverse VIX ST ETN to Potentially Pullback after Yesterday's 7.59% Rise
Comtex SmarTrend(R) - Mon Oct 20, 3:44PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $28.01 to a high of $30.56. Yesterday, the shares gained 7.6%, which took the trading range above the 3-day high of $29.48 on volume of 24.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XIV: 36.61 (+0.54)

Shares of XIV Down 24.3% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Oct 14, 9:18AM CDT
SmarTrend identified a Downtrend for VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) on September 29th, 2014 at $38.96. In approximately 2 weeks, VelocityShares Daily Inverse VIX ST ETN has returned 24.33% as of today's recent price of $29.48.
XIV: 36.61 (+0.54)

After Yesterday's Decline of 10.51%, VelocityShares Daily Inverse VIX ST ETN Offers Investors Better Value
Comtex SmarTrend(R) - Mon Oct 13, 3:52PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $28.27 to a high of $32.89. Yesterday, the shares fell 10.5%, which took the trading range below the 3-day low of $31.80 on volume of 31.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XIV: 36.61 (+0.54)

VelocityShares Daily Inverse VIX ST ETN Set to Possibly Rebound After Yesterday's Selloff of 9.07%
Comtex SmarTrend(R) - Thu Oct 09, 3:41PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $35.74 to a high of $39.23. Yesterday, the shares fell 9.1%, which took the trading range below the 3-day low of $36.01 on volume of 37.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XIV: 36.61 (+0.54)

After Yesterday's Rally of 5.99% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Oct 03, 3:43PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $38.78 to a high of $40.41. Yesterday, the shares gained 6.0%, which took the trading range above the 3-day high of $39.33 on volume of 17.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XIV: 36.61 (+0.54)

Look for Shares of VelocityShares Daily Inverse VIX ST ETN to Potentially Rebound after Yesterday's 4.76% Sell Off
Comtex SmarTrend(R) - Mon Sep 29, 3:46PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $38.10 to a high of $39.82. Yesterday, the shares fell 4.8%, which took the trading range below the 3-day low of $38.78 on volume of 17.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XIV: 36.61 (+0.54)

SmarTrend Watching for Potential Rebound in Shares of VelocityShares Daily Inverse VIX ST ETN After 3.58% Loss
Comtex SmarTrend(R) - Mon Sep 22, 4:20PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $42.57 to a high of $44.03. Yesterday, the shares fell 3.6%, which took the trading range below the 3-day low of $43.28 on volume of 10.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XIV: 36.61 (+0.54)

VelocityShares Daily Inverse VIX ST ETN Set to Possibly Rebound After Yesterday's Selloff of 2.54%
Comtex SmarTrend(R) - Mon Sep 15, 3:53PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $41.19 to a high of $42.35. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $41.82 on volume of 9.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XIV: 36.61 (+0.54)

VelocityShares Daily Inverse VIX ST ETN Falls 2.71% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Sep 09, 4:03PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $42.81 to a high of $44.06. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $43.02 on volume of 8.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XIV: 36.61 (+0.54)

SmarTrend Watching for Potential Pullback in Shares of VelocityShares Daily Inverse VIX ST ETN After 1.16% Gain
Comtex SmarTrend(R) - Wed Sep 03, 3:45PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $43.10 to a high of $43.80. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $43.69 on volume of 6.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XIV: 36.61 (+0.54)

SmarTrend Watching for Potential Pullback in Shares of VelocityShares Daily Inverse VIX ST ETN After 3.99% Gain
Comtex SmarTrend(R) - Mon Aug 11, 3:51PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $37.67 to a high of $39.51. Yesterday, the shares gained 4.0%, which took the trading range above the 3-day high of $37.87 on volume of 13.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XIV: 36.61 (+0.54)

Look for Shares of VelocityShares Daily Inverse VIX ST ETN to Potentially Rebound after Yesterday's 6.87% Sell Off
Comtex SmarTrend(R) - Tue Aug 05, 3:43PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $35.95 to a high of $38.99. Yesterday, the shares fell 6.9%, which took the trading range below the 3-day low of $36.92 on volume of 25.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XIV: 36.61 (+0.54)

22.5% Return Seen to Date on SmarTrend VelocityShares Daily Inverse VIX ST ETN Call (XIV)
Comtex SmarTrend(R) - Thu Jul 31, 5:27PM CDT
SmarTrend identified an Uptrend for VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) on April 2nd, 2014 at $32.43. In approximately 4 months, VelocityShares Daily Inverse VIX ST ETN has returned 22.53% as of today's recent price of $39.73.
XIV: 36.61 (+0.54)

Watch for VelocityShares Daily Inverse VIX ST ETN to Potentially Rebound After Falling 2.92% Yesterday
Comtex SmarTrend(R) - Fri Jul 25, 3:49PM CDT
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $43.59 to a high of $44.47. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $44.43 on volume of 8.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XIV: 36.61 (+0.54)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Your Rights as a Humacyte, Inc. Investor

Updated Category News Views 110

Understanding Your Rights as a Humacyte, Inc. Investor Humacyte, Inc. (NASDAQ: HUMA) has recently captured the attention of investors due to certain legal developments affecting its share value. If you are a shareholder who purchased shares during the specific class period of May 10, 2024, to October 17, 2024, you may want to take active steps to protect your investment...

Continue Reading
Jim Chanos Raises Concerns About Oracle's Accounting Issues

Updated Category News Views 552

Chanos Questions Oracle's Accounting Practices Notable short-seller Jim Chanos has recently highlighted some serious concerns regarding Oracle Corp's accounting integrity. He has voiced skepticism about the company's massive project backlog, especially a significant $300 billion deal partnered with OpenAI, emphasizing that its operational realization is years away and...

Continue Reading
Cyrus Biotechnology Advances Novel IgG Therapy with No Antibodies

Updated Category News Views 171

Promising Developments by Cyrus Biotechnology Cyrus Biotechnology, Inc. has unveiled groundbreaking data showcasing the effectiveness of its engineered IgG-degrading enzyme, CYR241, in a unique rabbit redosing model. This enzyme demonstrates significant therapeutic activity without the formation of anti-drug antibodies (ADAs) upon repeated administration. Understanding...

Continue Reading
GreenPower Motor Company: Strengthening Its Financial Future

Updated Category News Views 241

GreenPower Motor Company Secures New Term Loan Funding GreenPower Motor Company Inc. (NASDAQ: GP), an innovator in the production and distribution of all-electric medium and heavy-duty vehicles, recently completed the closing of the fifth tranche of its secured term loan offering. This strategic move aims to bolster its operational capabilities, particularly in the cargo,...

Continue Reading
Unlocking the Future: Insights into the Cloud Industry 2025

Updated Category News Views 226

The Promising Future of the Global Cloud Industry The global cloud industry is on a fast track to remarkable growth. Recent research indicates that the market is poised to expand from approximately USD 1,091.4 billion in one year to an impressive USD 1,256.8 billion by 2025. This represents a noteworthy year-over-year increase of about 15.1%. With such staggering figures,...

Continue Reading